These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35 related articles for article (PubMed ID: 10840756)
1. Enzyme assays for protein kinase C activity. Sando JJ; Beals JK Methods Mol Biol; 2003; 233():63-76. PubMed ID: 12840498 [No Abstract] [Full Text] [Related]
2. Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases. Beeton CA; Chance EM; Foukas LC; Shepherd PR Biochem J; 2000 Sep; 350 Pt 2(Pt 2):353-9. PubMed ID: 10947948 [TBL] [Abstract][Full Text] [Related]
3. Role of PI3-kinase and PI4-kinase in actin polymerization during bovine sperm capacitation. Etkovitz N; Rubinstein S; Daniel L; Breitbart H Biol Reprod; 2007 Aug; 77(2):263-73. PubMed ID: 17494916 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of phospholipase Cgamma1 activity during EGF-induced proliferation of corneal epithelial cells: effect of phosphoinositide-3 kinase. Islam M; Akhtar RA Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1472-8. PubMed ID: 11381049 [TBL] [Abstract][Full Text] [Related]
8. Biochemical assays for multiple activation states of protein kinase C. Yamamoto T; Matsuzaki H; Kamada S; Ono Y; Kikkawa U Nat Protoc; 2006; 1(6):2791-5. PubMed ID: 17406536 [TBL] [Abstract][Full Text] [Related]
9. The role of phosphoinositide 3-kinase pathway inhibitors in the treatment of lung cancer. Engelman JA Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4637-40. PubMed ID: 17671156 [TBL] [Abstract][Full Text] [Related]
10. The phosphoinositide 3-kinase pathway and cancer. Stokoe D Expert Rev Mol Med; 2005 Jun; 7(10):1-22. PubMed ID: 15938760 [TBL] [Abstract][Full Text] [Related]
11. Pulse-chase analysis of protein kinase C. Takahashi M; Ono Y Methods Mol Biol; 2003; 233():163-70. PubMed ID: 12840506 [No Abstract] [Full Text] [Related]
12. Bioassays for the measurement of neutralizing antibodies in serum (SNFs). Indelicato SR Dev Biol (Basel); 2003; 112():113-25. PubMed ID: 12762510 [TBL] [Abstract][Full Text] [Related]
13. Class II phosphoinositide 3-kinase is activated by insulin but not by contraction in skeletal muscle. Soos MA; Jensen J; Brown RA; O'Rahilly S; Shepherd PR; Whitehead JP Arch Biochem Biophys; 2001 Dec; 396(2):244-8. PubMed ID: 11747303 [TBL] [Abstract][Full Text] [Related]
14. Class IA phosphoinositide 3-kinase isoforms and human tumorigenesis: implications for cancer drug discovery and development. Wee S; Lengauer C; Wiederschain D Curr Opin Oncol; 2008 Jan; 20(1):77-82. PubMed ID: 18043260 [TBL] [Abstract][Full Text] [Related]
15. Role of class II phosphoinositide 3-kinase in cell signalling. Falasca M; Maffucci T Biochem Soc Trans; 2007 Apr; 35(Pt 2):211-4. PubMed ID: 17371240 [TBL] [Abstract][Full Text] [Related]
18. Measurement of phosphoinositide 3-kinase and its products to study adipogenic signal transduction. Sorisky A; Gagnon A Methods Mol Biol; 2008; 456():317-25. PubMed ID: 18516572 [TBL] [Abstract][Full Text] [Related]